IL15 and neoplasm: Tumor cell-killing by unprimed CD8 T cells co-cultured overnight with IL-15 DCs was 2–3 fold enhanced against NB4, SH-SY5Y, and U266 cells, i.e., 17.43 ± 14.45% →  43.32 ± 12.32%, 8.46 ± 3.27% → 23.87 ± 6.62%, and 8.82 ± 4.35 → 23.17 ± 10.61%, respectively.